Towards Dual Antibacterial Drug-Nanoparticle (DADNP) Systems Computational Design

Karel Diéguez-Santana
2021 Proceedings of MOL2NET'21, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 7th ed.   unpublished
The emergence of Multidrug-Resistant (MDR) strains promotes the improvement of Antibacterial Drugs (AD). Some nanoparticles (NP) may be AD carriers, but some have antibacterial activity per se. This opens a window of opportunity for the design of Dual Antibacterial Drug-Nanoparticle (DADNP) systems. DADNP discovery is a slow process due to the high number of combinations of NP vs. AD compounds, assays, etc.
doi:10.3390/mol2net-07-11194 fatcat:lpfeabaoh5fs7anb5dig3zry4q